Suppr超能文献

全身麻醉诱导后中心静脉压作为血流导向容量优化的辅助手段

Central venous pressure as an adjunct to flow-guided volume optimisation after induction of general anaesthesia.

作者信息

Hahn Robert G, He Rui, Li Yuhong

机构信息

Research Unit, Södertälje Hospital, Södertälje, Sweden.

出版信息

Anaesthesiol Intensive Ther. 2016;48(2):110-5. doi: 10.5603/AIT.a2015.0066. Epub 2015 Oct 26.

Abstract

BACKGROUND

Although the central venous pressure (CVP) is often used as a guide to volume status in major surgery and intensive care, fluid therapy should be guided by the response of the stroke volume (SV) to a fluid bolus. The present study evaluates whether the central venous pressure (CVP) can serve as an adjunct to decisions of whether or not fluid should be infused.

METHODS

Stroke volume (SV) and stroke volume variation (SVV) was monitored with FloTrac/Vigileo and the CVP were measured in 80 patients just before general anaesthesia was induced (baseline) and then, before each of three successive bolus infusions of 3 mL kg⁻¹ of 6% hydroxyethyl starch 130/0.4. A patient showed fluid responsiveness and was denoted a "responder" if SV increased by ≥10% from the bolus infusion.

RESULTS

The CVP was higher in non-responders (mean 7.2 mm Hg) than in responders (mean 5.8 mm Hg, P < 0.0001). In non-responders but not in responders, the absence or presence of a rise in CVP improved the prediction of whether the patient would show fluid responsiveness during the next fluid bolus. For example, if no rise in CVP occurred the chance was 48% of subsequent fluid responsiveness, while this chance was only 9% for those who had an increase in CVP (P < 0.004). There was only a fair concordance between fluid responsiveness as indicated by SV and SVV (Cohen´s kappa 0.28).

CONCLUSIONS

A low CVP suggests that the patient is lower on the Frank-Starling curve than indicated by SV as measured by FloTrac/Vigileo.

摘要

背景

尽管中心静脉压(CVP)常被用作重大手术和重症监护中容量状态的指导指标,但液体治疗应以每搏量(SV)对液体冲击量的反应为指导。本研究评估中心静脉压(CVP)是否可作为决定是否应输注液体的辅助指标。

方法

采用FloTrac/Vigileo监测80例患者的每搏量(SV)和每搏量变异度(SVV),并在全身麻醉诱导前(基线)以及随后连续三次每次输注3 mL/kg的6%羟乙基淀粉130/0.4之前测量CVP。如果每搏量从液体冲击量输注后增加≥10%,则该患者显示液体反应性,并被标记为“反应者”。

结果

无反应者的CVP(平均7.2 mmHg)高于反应者(平均5.8 mmHg,P<0.0001)。在无反应者而非反应者中,CVP升高与否改善了对患者在下一次液体冲击量时是否会出现液体反应性的预测。例如,如果CVP未升高,随后出现液体反应性的概率为48%,而CVP升高者的概率仅为9%(P<0.004)。SV和SVV所显示的液体反应性之间仅有中等程度的一致性(Cohen's kappa 0.28)。

结论

低CVP表明患者处于Frank-Starling曲线的较低位置,低于FloTrac/Vigileo测量的SV所提示的位置。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验